Loading...

Haemonetics Corporation

HAE•NYSE
Healthcare
Medical - Instruments & Supplies
$60.44
$0.82(1.38%)
U.S. Market is Open • 10:18

Haemonetics Corporation (HAE) Stock Overview

Explore Haemonetics Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.8B
P/E Ratio15.89
EPS (TTM)$3.63
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$66.56
3 Months$71.86
1 Year Target$58.68

HAE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haemonetics Corporation (HAE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.50, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $58.68.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.89 and a market capitalization of 2.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.60%
5-Day Change
-1.17%
1-Month Change
5.86%
3-Month Change
-12.85%
6-Month Change
17.01%
Year-to-Date (YTD) Change
-25.17%
1-Year Change
-3.13%
3-Year Change
-29.27%
5-Year Change
-11.52%
All-Time (Max) Change
910.19%

Contact Information

https://www.haemonetics.com
781 848 7100
125 Summer Street, Boston, MA, 02110

Company Facts

3,657 Employees
IPO DateMay 10, 1991
CountryUS
Actively Trading

Frequently Asked Questions